Nassoma Bumpers

A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma

C. Flowers, S. Lonial, J. Kaufman, 2015, British journal of haematology.

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

C. Flowers, S. Lonial, J. Kaufman, 2018, Blood.

A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non‐Hodgkin's lymphoma

C. Flowers, S. Lonial, J. Kaufman, 2015, British journal of haematology.